---
document_datetime: 2023-09-21 21:51:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cetrotide-epar-all-authorised-presentations_en.pdf
document_name: cetrotide-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7605293
conversion_datetime: 2025-12-25 09:14:35.816241
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | Invented Name   | Strength   | Pharmaceutical form                           | Route of administration   | Immediate Packaging                                      | Content (concentration)                    | Pack size                                              |
|------------------|-----------------|------------|-----------------------------------------------|---------------------------|----------------------------------------------------------|--------------------------------------------|--------------------------------------------------------|
| EU/1/99/100/001  | Cetrotide       | 0.25 mg    | Powder and solvent for solution for injection | Subcutaneous use          | Powder: vial (glass) Solvent: pre-filled syringe (glass) | Powder: 0.25 mg Solvent: 1 mL (0.25 mg/mL) | 1 vial + 1 pre-filled syringe + 2 injection needles    |
| EU/1/99/100/002  | Cetrotide       | 0.25 mg    | Powder and solvent for solution for injection | Subcutaneous use          | Powder: vial (glass) Solvent: pre-filled syringe (glass) | Powder: 0.25 mg Solvent: 1 mL (0.25 mg/mL) | 7 vials + 7 pre-filled syringes + 14 injection needles |